Physician profile
Frank Bateman
NPI 1831262567
$2,993.08
in general payments reported to CMS, 2019-2025
16 companies · $910 in 2025
The $910 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $634 · 2022: $477 · 2023: $588 · 2024: $384 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,882.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $871.02 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $372.18 | 2021-2025 | |
| Pfizer INC. | $321.92 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $208.14 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $189.11 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $182.68 | 2021-2025 | Dupixent |
| Ucb, INC. | $170.49 | 2021-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $170.35 | 2021-2023 | Ilumya |
| Amgen INC. | $126.31 | 2021-2023 | Otezla |
| Lilly USA, LLC | $116.56 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $77.26 | 2021-2025 | Nemluvio |
| Leo Pharma INC. | $58.44 | 2025 | Adbry |
| Incyte Corporation | $49.25 | 2022-2023 | Opzelura |
| Genzyme Corporation | $43.43 | 2023-2024 | |
| Dermavant Sciences, INC. | $20.39 | 2023 | Vtama |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.55 | 2023 | Cyltezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Bateman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.